Obtaining insurance after DNA diagnostics: a survey among hypertrophic cardiomyopathy mutation carriers

Hypertrophic cardiomyopathy (HCM) is a common hereditary heart disease associated with increased mortality. Disclosure of DNA test results may have social implications such as low access to insurance. In the Netherlands, insurance companies are restricted in the use of genetic information of their c...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Christiaans, Imke, Kok, Tjitske M, van Langen, Irene M, Birnie, Erwin, Bonsel, Gouke J, Wilde, Arthur A M, Smets, Ellen M A
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2010
Matèries:
Short Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2987186/
https://ncbi.nlm.nih.gov/pubmed/19672285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/ejhg.2009.145
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars